Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias
Authors:
- Mark A. HlatkyMHMark A. Hlatky
- Derek B. BoothroydDBDerek B. Boothroyd
- Iain M. JohnstoneIJIain M. Johnstone
- Frank I. MarcusFMFrank I. Marcus
- Elizabeth HahnEHElizabeth Hahn
- Vernon HartzVHVernon Hartz
- Jay W. MasonJMJay W. Mason
Open Access
- 1 February 1997
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 50 (2) , 185-193
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cost of Initial Therapy in the Electrophysiological Study Versus ECG Monitoring Trial (ESVEM)Circulation, 1995
- A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- Guidelines for Economic Analysis of Pharmaceutical ProductsPharmacoEconomics, 1993
- Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators.Circulation, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- A Clinician's Guide to Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1990
- The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators.Circulation, 1989
- A Randomized Clinical Trial of the Noninvasive and Invasive Approaches to Drug Therapy of Ventricular TachycardiaNew England Journal of Medicine, 1987
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977